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An Overview
Scientists have known since the 1890s that insects are vulnerable to 
diseases. However, it was not until the early 1950s that field demon-
strations by Steinhouse in California led to the commercial production 
of biopesticides. The federal government registered the first microbial 
product in 1948, the bacterium Bacillus popillae, to control the Japanese 
beetle in turf. Although many entomopathogens of insects have been 
isolated and described, only a few have any real potential as microbial 
pesticides. Interest in microbials has accelerated since the late 1960s 
for several reasons: 1 environmental concerns due to dependence on 
chemical pesticides and their effect on groundwater pollution, residues 
on food crops, and nontarget organisms; Z development of resistance 
to chemicals; 3 interest in integrated pest management; and 4 recent 
developments in biotechnology; i.e., recombinant DNA technology.
Most entomopathogens must be ingested in order to cause an in-
fection. The exceptions are the fungi, which infect externally and the 
nematodes which actively seek out and attack their host. Some may 
question whether nematodes should be considered as an entomopatho- 
gen; however, most insect pathologists do include them in this catego-
ry and they are being actively commercialized for control of soil insect 
pests. Although some organisms such as bacteria and fungi can be pro-
duced in liquid culture, the viruses and microsporidia are still produced 
in vivo.
The speed of kill by biopesticides is slow as compared to most chem-
ical pesticides. This is a problem in the eyes of the public who have 
been conditioned to the fast-acting results provided by chemical pesti-
cides. There is a recognized need to educate the public about the mode 
of action of microbial pesticides and their potential use in integrated 
pest management systems. Characteristics of the major groups of en- 
tomopathogens that are used as biopesticides are discussed in the fol-
lowing sections.
NEMATODES
Nematodes occur naturally in soils and they possess a very wide host 
range. They are relatively easy to mass produce and apply, however, 
their persistence in soil is limited to a few weeks. Since they are ex-
empt from Environmental Protection Agency (EPA) registration re-
quirements, they are being actively pursued by industry as a control 
alternative. Several laboratories are focusing on application technol-
ogy for using nematodes against soil insects, and they are providing 
new formulations that include nematodes encapsulated in calcium 
alginate gels or desiccated species applied with baits. Results from field 
trials using nematodes have been inconsistent. The soil system as a 
medium is very complex, consequently moisture, pH, texture, and 
antagonistic organisms can effect the efficacy of nematodes individu-
ally or collectively.
FUNGI
There are about 750 species of fungi that are known parasites or patho-
gens of arthropod pests in terrestrial and aquatic systems. Fungal epi-
zootics can sometimes decimate populations and their effect can be 
very dramatic. Fungi are unique in that they infect through the cuticle 
rather than per os, so they have potential use against insects with pier- 
cing/sucking mouthparts.
There are ten genera that are amenable to semisolid fermentation 
and are being mass-produced by industry and government agencies 
throughout the world. There is a concerted effort by industry in the 
U.S. to develop Beauvaria bassiana as a soil biopesticide. It is being used 
against the pecan weevil in Georgia, the lesser cornstalk borer in 
Florida, as a prophylactic treatment on cottonwood cuttings in nur-
series, and even in gallery injections for pests such as the carpenter- 
worm. Beauvaria bassiana is registered in France by a company called 
Calliope. Another company in Colorado has recently requested
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permission from EPA to conduct small field testing of a Brazilian 
isolate of B. bassiana for control of the fire ant. Unfortunately, as in the 
case of many microbials, levels causing excellent mortality rates in the 
lab have not been efficacious in the field. Microhabitat conditions, 
especially temperature and relative humidity, are critical for germina-
tion and infection by fungi and frequently compromise field efficacy.
PROTOZOA
Among the protozoa, the only group considered to have potential as a 
biopesticide is the microsporidia. Microsporidia generally produce 
chronic rather than acute disease in insects, consequently their effect 
on populations is not as dramatic as the epizootics caused by bacteria, 
fungi, or viruses. However, they do cause debilitating effects on pests 
such as prolonged development, reduced fecundity, and, in some cases, 
behavioral changes. Microsporidia are reported to act as a stressor in 
insect populations, thus predisposing individuals to attack by other 
organisms such as viruses. Many microsporidia are vertically transmit-
ted transovarially to subsequent generations, which is a desirable cha-
racteristic not common to other entomopathogens. They are known to 
infect over 100 different species of mosquitoes and several major forest 
defoliators such as the spruce budworm, gypsy moth, and forest tent 
caterpillar.
One species, Nosema locustae, is registered in the U.S. as a bait for-
mulation for grasshopper control. However, microsporidia, like nema-
todes and fungi, probably have greater potential when used in inocula-
tive or augmentative releases to effect classical biological control.
BACTERIA
Among the entomopathogens, bacteria and their toxins are the subject 
of most interest in the field of biotechnology. One species, Bacillus 
thuringiensis (Bt), is an ideal organism for large-scale commercial pro-
duction because it can be produced in submerged cultures with stan-
dard methods and fermentation equipment. Annual sales of Bt have 
been estimated at $35-45 million per year representing approximately 
one percent of the $5 billion in pesticides marketed worldwide.
The commercialization of Bt expanded in the late 1960s with the 
isolation and development of the HD-1 Kurstaki strain. This strain, 
which was approximately 15 times more efficacious than other availa-
ble strains, was accepted as the International Standard and is recom-
mended for use against at least 50 different lepidopteran pests.
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Over the years, the acceptance and use of Bt products has been 
hindered by their inconsistent performance in the field. This in turn 
has been reflected by the emergence and departure of several Bt 
producers in the past five to ten years.
The interest in and development of Bt related research has exploded 
in recent years, due mainly to the isolation of new strains, the emer-
gence of genetic engineering, and our interest in the delta endotoxin, 
which is produced in the fermentation process. Bacillus thuringiensis is 
a spore-forming bacterium that, when cultured under the appropriate 
conditions, forms a crystalline parasporal inclusion body called a crys-
tal protein which contains the delta endotoxin. Usually one crystal is 
produced per cell, although in some strains there are up to three crys-
tals per cell. One strain, Bt var. israelensis, exhibits a high level of in-
secticidal activity for mosquito and black fly larvae. It has been used 
successfully against both pests in Africa, Germany, and in abatement 
districts in the United States and is extremely important in public 
health programs. Other strains have been isolated and recently regis-
tered by EPA that are active against Coleoptera (Bt var. tenebrionis and 
var. San Diego). There is a flurry of commercial interest to develop and 
evaluate these strains against the Colorado potato beetle, the elm leaf 
beetle, the yellow mealworm, and other coleopteran pests.
A tremendous amount of effort is going into the research and deve- 
opment of Bt. For example, certain strains can be induced to produce 25 
to 30 times the normal amount of endotoxin by modifying the culture 
media or temperature; other strains have been developed with toxic 
proteins that decompose more slowly in the environment. A combi-
nation of strains has been found to be synergistic against hard to kill 
species; sprayable, starch-encapsulated formulations are now being 
developed for use against the corn borer. These formulations protect Bt 
from ultraviolet radiation and can also be used to incorporate phagos- 
timulants. Both these processes have been known to enhance persis-
tence and effectiveness in the field for up to 12 days.
One commercial biotechnology firm has developed a novel insecti-
cidal delivery system for the delta endotoxin, called MCAP®. The 
toxin is microencapsulated within a nonviable cell of Pseudomonas 
fluorescence, which is a soil inhabiting, plant colonizing, nonpathogenic 
microbe. This process seems to enhance field persistence. Genetic 
engineering technology is also capable of producing recombinant
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organisms of P. fluorescence and Escherichia coli.that express the delta 
endotoxin of Bt. Some foresee the day when many major insect pests 
will have a tailor-made Bt product available for use against it.
INSECT-RESISTANT TRANSGENIC PLANTS
Molecular biologists using gene insertion techniques have produced a 
third approach to pest control—plants that produce insecticidal or 
antifeedant proteins continuously in the field. The first prototype 
products, tobacco and tomato plants that produce delta endotoxins of 
Bt to control larvae of the hornworms, have already undergone one or 
two seasons of field trials. Field tests of genetically engineered cotton 
have been approved by APHIS (the Animal and Plant Health Inspec-
tion Service). The agency is currently reviewing applications for field 
trials using soybeans, alfalfa and potatoes. Based on experience with 
traditionally bred crop lines, it is projected that the first genetically 
engineered insect resistant seed will reach the marketplace between 
1992 and 1995.
There are both advantages and disadvantages associated with the 
development of transgenic plants. From the grower’s perspective, 
there would be a reduction in application costs, equipment, chemicals, 
and the application itself. The protection would be effective independ-
ent of weather conditions and there would be better plant coverage, 
especially of those tough-to-reach plant parts. All of this would trans-
late into greater profits. From industry’s perspective, the cost to dis-
cover, develop, register, and produce a new chemical is estimated at 
about $25 million and up. Conversely, the cost of a new crop variety 
has been estimated to be closer to $ 1 to $2 million. From the environ-
mentalist’s perspective, there is no concern about spray drift, ground- 
water contamination, and effects on nontarget organisms because the 
endotoxins are part of the plant tissue. Documenting the safety to hu-
mans will be easier, since an inserted gene would be fully characterized 
and there would be no need for residue analysis or toxicology.
Regarding disadvantages, there is concern that resistance may deve-
lop sooner since the toxin will be exposed continuously to the target 
pest; some evidence of this has been reported when Bt was used against 
the Indian meal moth in storage bins. Some regulatory uncertainties 
still exist that could make the burden of registration potentially pro-
hibitive. Theoretically, a modified crop could be considered a pesticide 
by EPA, a food additive by the Food and Drug Administration (FDA), 
and a plant pest by APHIS.
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Currently, there are some limitations concerning the insertion of 
genes into major crops, particularly grains. There are also some ques-
tions regarding patent availability and whether or not an invention or 
investment could be protected.
VIRUSES
More than twenty groups of viruses are known to be pathogenic for 
insects. Of these, the most interest has been directed toward nuclear 
polyhedrosis viruses (NPVs), and, to a lesser degree, the granulosis vi-
ruses. These viruses belong to the family Baculoviridae, and are refer-
red to as baculoviruses. The virions, or infectious agents, are cylindri-
cal and enclosed within an inclusion body that is polyhedral in shape, 
thus they are called polyhedral inclusion bodies or PIBs. These inclu-
sion bodies are similar to a bacterial spore or a fungal conidium in that 
they are resistant to desiccation, very stable, and thus can be stored in 
a viable state for many years.
Disease caused by viruses are usually fatal. Death of larvae usually 
occurs three to six days after the first symptoms appear, however this 
may be delayed for several days under varying meteorological condi-
tions in the field. Epizootics caused by viruses, especially in forest 
insects, are dramatic and frequently cause total collapse of popula-
tions. Unfortunately, these epizootics usually occur only after very 
dense, defoliating populations are stressed by lack of suitable host 
foliage; by this time the damage and impact caused by the pest 
population has already been realized.
The first virus registered in the U.S. was Elcar® (1975) for control 
of Heliothis sp. on cotton, however since then, commercialization of 
viruses has been at a standstill. Subsequently, the federal government 
was involved in the development and registration of three forest insect 
viruses. The reluctance of industry to develop and register viruses can 
be attributed to their host specificity and the lack of predictable and 
expanding markets for viral products. On the other hand, more than 
150 commercial laboratories are using baculoviruses as an expression 
vector system to manufacture proteins. Viruses can be engineered to 
produce massive amounts of protein in a short period of time. Some 
recent development in the use of baculoviruses are listed below:
—The University of California has recently obtained an experimental
use permit to evaluate codling moth granulosis virus on pear, apple,
and walnut. This pilot production project is a joint venture be-
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tween a nonprofit grower’s cooperative, IR-4, and the California 
Legislature.
—In many Third World countries, conditions are ideal for developing 
baculoviruses, because inexpensive labor is abundant; producing 
viruses in live insects is a very labor-intensive industry. Most of 
these countries do not have the hard currency available to import 
chemical pesticides or even commercially produced Bt. There are 
several good examples where government sponsored farmer coop-
eratives are producing baculoviruses for the control of agricultural 
pests. These include the viruses for the velvet bean caterpillar in 
Brazil, alfalfa looper in Guatemala, beet army worm in Thailand, 
and the cotton Ieafworm in Egypt.
—Field efficacy of the gypsy moth virus, Gypchek, was improved sub-
stantially by the addition of an inexpensive sunscreen to the tank 
mix. The product, Orzan LS®, is a lignosulfonate and a waste by-
product of the pulping industry.
—Agricultural Research Service scientists, in collaboration with in-
dustry, have successfully produced quantities of the gypsy moth 
NPV in a new fat body cell culture system. This could be a major 
breakthrough in the commercialization of this virus product.
The potential role of biotechnology in the development of bacu-
loviruses is unlimited. Recombinant DNA technology offers many 
new avenues to improve the pathogenicity and effectiveness of bacu-
loviruses. From 1986 to 1988, scientists in England obtained permits to 
release a genetically altered baculovirus in a screen-contained small- 
scale field tests. They inserted an innocuous genetic marker to follow 
the fate of the virus in the environment and distinguish it from 
naturally occurring viruses in the field.
In 1989, scientists at the Boyce Thompson Institute for Plant Re-
search received EPA approval to release a genetically disabled isolate of 
Autographa californica virus, (cabbage looper) into field plots in order to 
follow its survival and spread under natural conditions; in this case the 
polyhedrin gene has been deleted. Using genetic engineering, it may be 
possible to improve viral pesticides by inserting toxin or hormone 
genes to improve direct toxicity, alter behavior, or arrest development 
in target pest populations.
REGULATORY ISSUES
Microorganisms intended for use as pesticides are subject to the Fede-
ral Insecticide, Rodenticide and Fungicide Act (F1FRA). The guidelines
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for the registration of biorational pesticides, referred to as Subdivision 
M guidelines, were issued by EPA in 1982. A revision of FIFRA guide-
lines which has been pending since 1986, has just been released by EPA 
and is now available. Some of the requirements for Tier-1 testing have 
been relaxed, which is certainly good news for those who are trying to 
register microbial products.
A statement of policy on microbial products of biotechnology and 
nonindigenous microorganisms was issued in the Federal Register in 
June of 1986. Microbials are distinguished from conventional chemical 
pesticides by their unique mode of action, their low use volume, and 
their target species specificity. Each new variety or strain of microbial 
pesticide must be evaluated and may be subject to additional data re-
quirements. Genetically engineered organisms used as pesticides will 
be subject to additional data on a case-by-case basis depending on the 
organism, the patent organism, and the proposed use pattern.
The major categories of data required will still include product che-
mistry, wildlife and aquatic toxicology, and environmental fate. Satis-
fying these data requirements will be expensive and time-consuming. 
The recent development of new strains of Bt and increased submissions 
of recombinant products by new biotechnology companies has put 
tremendous strain on the EPA and has slowed the processing of new 
registration and experimental use permits. Obviously, the goal of regu-
latory oversight should be to ensure safety while minimizing unneces-
sary or counterproductive regulatory burdens.
CONCLUSION
Microbial pesticides can play an important role in pest management 
systems, either as a principal or supplementary control tactic. How-
ever, they are not a panacea and should not be considered as such.
There is a need to continue the isolation and evaluation of new and 
more virulent strains of microorganisms for potential use as microbial 
pesticides. Along these lines, the introduction of new exotic organisms 
against native pest insects should be pursued and insect pathologists 
need to be personally involved in foreign exploration for these organ-
isms. Although there have been a few successful applications of this 
classical approach to biological control, the approach has been under-
utilized.
Biopesticides
The success in using microbial pesticides has been compromised by 
a lack of research and development in the area of formulation and 
aerial application technology; methodologies being used were devel-
oped years ago for applying chemical pesticides. The most promising 
microbial products will fail unless we learn how to apply them pro-
perly and enhance their persistence on foliage.
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